Brachytherapy of intra ocular tumors using ‘BARC I-125 Ocu-Prosta seeds’: An Indian experience
Vikas Khetan(Sankara Nethralaya), Ashutosh Dash(Bhabha Atomic Research Centre), Pramod Bhende(Sankara Nethralaya), Lingam Gopal(Sankara Nethralaya), Aditi Gupta(Sankara Nethralaya), Tarun Sharma(Sankara Nethralaya), MaheshP Shanmugam(Eye Hospital in Bangalore), Siva Muthukumar(Cancer Institute (WIA)), Thayalan Kuppuswamy(Dr. Kamakshi Memorial Hospital), SK Saxena(Bhabha Atomic Research Center Hospital), Rathan M. Subramaniam(Dunedin Public Hospital)
Cited by 11
Related Papers
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
|Nuclear Medicine and Molecular Imaging|2015|375
Sustained Availability of <sup>99m</sup>Tc: Possible Paths Forward
|Journal of Nuclear Medicine|2012|140
Peptide Receptor Radionuclide Therapy: An Overview
|Cancer Biotherapy and Radiopharmaceuticals|2015|122
Targeted Radionuclide Therapy - An Overview
|Current Radiopharmaceuticals|2013|117
Development of an electrochemical 90Sr–90Y generator for separation of 90Y suitable for targeted therapy
|Nuclear Medicine and Biology|2008|99